Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000295053 (annotated as "novel transcript, antisense to NBPF6") is a human long non-coding RNA (lncRNA) gene located on chromosome 1, classified as an RNA gene of the lncRNA class[5][1]. It does not encode a protein, and its biological function, disease involvement, and clinical relevance are not characterized in the literature or standard curated databases[5][1]. The closest protein-coding gene is NBPF6 (Neuroblastoma breakpoint family member 6), but ENSG00000295053 is distinct from NBPF6 itself and is not considered a protein, enzyme, receptor, transporter, or recognized therapeutic target[5][1]. There are no known aliases beyond its Ensembl gene ID, and all molecular and biomedical role categories remain undefined for this lncRNA transcript.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, antisense to NBPF6.